Has Brandi Creel received payments from drug or device companies?

Yes. Drug and device makers reported $4,967 in general payments to Brandi Creel across 264 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Brandi Creel did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Brandi Creel come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Brandi Creel

Nurse Practitioner · Florence, ALNPI 1184933483

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.7% of the total across 264 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 52 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,870 and has fallen 86.9% since, to $246 in 2025. Among nurse practitioner clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,967in general payments, 2019–2025

Across 264 payments — averaging $18.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$878
AstraZeneca$440
Seagen Inc.$400
Johnson & Johnson$348
Merck$242
E.r. Squibb & Sons, L.L.C.$234
plus $2K from 46 others

What the payments were for

Food & beverage$4,80197%
Education$1663%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	55	$878
AstraZeneca(2 entities)	22	$440
Seagen Inc.	21	$400
Johnson & Johnson(2 entities)	15	$348
Merck	12	$242
E.r. Squibb & Sons, L.L.C.	16	$234
Pharmacyclics LLC, An Abbvie Company	9	$156
AbbVie	7	$136
Incyte Corporation	7	$127
Exelixis Inc.	6	$121
Genentech USA, Inc.	6	$115
Sanofi	5	$112
Bristol Myers Squibb	6	$105
Boehringer Ingelheim	4	$103
Amgen	6	$103
Takeda Pharmaceuticals U.S.A., Inc.	4	$96
Pfizer	4	$74
Bayer	4	$73
Stemline Therapeutics Inc.	3	$71
Tersera Therapeutics LLC	3	$66
Eisai Inc.	3	$64
GSK	3	$53
Sumitomo Pharma America, Inc.	3	$53
Beigene USA, Inc.	3	$51
Array Biopharma Inc	2	$47
Pharmacosmos Therapeutics Inc.	2	$45
Blueprint Medicines Corporation	2	$44
Abbott	1	$39
Deciphera Pharmaceuticals Inc.	2	$37
Adaptive Biotechnologies Corporation	2	$35
Novo Nordisk	2	$33
AVEO Pharmaceuticals, Inc.	2	$32
Regeneron Healthcare Solutions, Inc.	2	$31
ADC Therapeutics America, Inc.	2	$29
Pharmaessentia USA Corporation	1	$28
Iovance Biotherapeutics, Inc.	1	$27
Novocure Inc.	1	$25
Dendreon Pharmaceuticals LLC	1	$25
Ipsen Biopharmaceuticals, Inc	1	$25
Jazz Pharmaceuticals Inc.	1	$23
Kyowa Kirin, Inc.	1	$23
Immunogen, Inc.	1	$21
Astellas Pharma US Inc	1	$20
Sobi, Inc	1	$20
Tolmar, Inc.	1	$20
Genmab U.S., Inc.	1	$18
EMD Serono, Inc.	1	$18
G1 Therapeutics, Inc.	1	$18
Karyopharm Therapeutics Inc.	1	$17
Servier Pharmaceuticals LLC	1	$15
Lilly USA, LLC	1	$14
Myovant Sciences Inc.	1	$13

How this compares

$4,967 in reported general payments places this provider in the 90th percentile of 1,505 nurse practitioner providers in Alabama.

See all nurse practitioner providers in Alabama →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Letrozole	18	$223
Levothyroxine Sodium	24	$122

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Florence

Jessi TidwellFlorence$14K
Karen Mann-BrownFlorence$10K
Erin TannerAlabaster$141K
Ardie Pack MabienMobile$29K
Ginger McDanielBirmingham$27K
Audrey MorganMontgomery$24K
Hollie CrutchfieldDothan$22K
Leah GravesBirmingham$21K
Lauren DowneyBirmingham$19K
Ashley HodgensMontgomery$19K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →